Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment

Human Gene Therapy

Volumn 11, Issue 10, 2000, Pages 1417-1428

  Paul, Stephane ^a   Snary, David ^b   Hoebeke, Johan ^c   Allen, Deborah ^b   Balloul, Jean Marc ^a   Bizouarne, Nadine ^a   Dott, Karine ^a   Geist, Michel ^a   Hilgers, Joseph ^d   Kieny, Marie Paule ^e   Burchell, Joy ^b   Taylor Papadimitriou, Joyce ^b   Acres, R Bruce ^a  

^a TRANSGENE S A   (France)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTERLEUKIN 12; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; VIRUS VECTOR;

ANIMAL CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CLONING VECTOR; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; KILLER CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; POXVIRUS; TARGET CELL; TUMOR CELL; TUMOR GROWTH; VACCINIA VIRUS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; BASE SEQUENCE; BIOSENSING TECHNIQUES; BLOTTING, WESTERN; CA-15-3 ANTIGEN; CELL DEATH; CELL SEPARATION; CHICK EMBRYO; DNA, COMPLEMENTARY; FLOW CYTOMETRY; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-12; MACROPHAGES; MICE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUCINS; NEOPLASMS; PEPTIDES; PHENOTYPE; POXVIRIDAE; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; VACCINIA VIRUS;

EID: 0034235913     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050057495     Document Type: Article

References (43)

1. ACRES, B., HAREUVENI, M., BALLOUL, J.M., and KIENY, M.P. (1993). VV-MUC1 immunization of mice: Immune response and protection against the growth of murine tumours bearing the MUC1 antigen. J. Immunother. 14, 136-143.
2. ALTENSCHMIDT, U., KLUNDT, E., and GRONER, B. (1997). Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression. J. Immunol. 159, 5509-5515.
3. ANILIONIS, A., WUNNER, W.H., and CURTIS, P.J. (1981). Structure of the glycoprotein gene in rabies virus. Nature (London) 294, 275-278.
4. BOLHUIS, R.L., and GRATAMA, J.W. (1998). Genetic re-targeting of T lymphocyte specificity. Gene Ther. 5, 1153-1155.
5. BROCKER, T., RIEDINGER, M., and KARJALAINEN, K. (1996). Redirecting the compete T cell receptor/CD3 signaling machinery towards native antigen via modified T cell receptor. Eur. J. Immunol. 26, 1770-1774.
6. BURCHELL, J., and TAYLOR-PAPADIMITRIOU, J. (1993). Effect of modification of carbohydrate side-chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene-product. Epithelial Cell Biol. 2, 155-162.
7. BURCHELL, J., GENDLER, S., TAYLOR-PAPADIMITRIOU, J., GIRLING, A., LEWIS, A., MILLIS, R., and LAMPORT, D. (1987). Development and chracterisation of breast-cancer reactive monoclonal-antibodies directed to the core protein of the human-milk mucin. Cancer Res. 47, 5476-5482.
8. CARROLL, M.W., OVERWIJK, W.W., CHAMBERLAIN, R.S., ROSENBERG, S.A., MOSS, B., and RESTIFO, N.P. (1997). Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: A murine tumor model. Vaccine 15(4), 387-394.
9. DOKURNO, P., BATES, P.A., BAND, H.A., STEWART, L.M.D., LALLY, J.M., BURCHELL, J.M., TAYLOR-PAPADIMITRIOU, J., SNARY, D., STERNBERG, M.J.E., and FREEMONT, P. (1998). Crystal structure at 1.95 Å resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition. J. Mol. Biol. 284, 713-728.
10. EBERL, L.P., GUILLOU, L., SARAGA, E., SCHROTER, M., FRENCH, L.E., TSCHOPP, J., and JUILLERAT-JEANNERET, L. (1999). Fas and fas ligand expression in tumor cells and in vascular smooth-muscle cells of coloic and renal carcinomas. Int. J. Cancer 81(5), 772-778.
11. EISCHEN, A., VINCENT, F., BERGERAT, J.P., LOUIS, B., FARADJI, A., BOHBOT, A., and OBERLING, F. (1991). Long term cultures of human monocytes in vitro. Impact of GM-CSF on survival and differentiation. J. Immunol. Methods 143, 209-221.
12. ESHHAR, Z., WARS, T., GROSS, G., and SCHINDLER, D.G. (1993). Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc. Natl. Acad. Sci. U.S.A. 90(2), 720-724.
13. GENDLER, S., TAYLOR-PAPADIMITRIOU, J., DUHIG, T., ROTHBARD, J., and BURCHELL, J. (1988). A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinoma is made up of tandem repeats. J. Biol. Chem. 263, 12820-12823.
14. GENDLER, S., LANCASTER, C.A., TAYLOR-PAPADIMITRIOU, J., DUHIG, T., PEAT, N., BURCHELL, J., PEMBERTON, L., LALANI, E.-N., and WILSON, D. (1990). Molecular cloning and expression of human tumour-associated polymorphic epithelial mucin. J. Biol. Chem. 265, 15286-15293.
15. GIRLING, A., BARTKOVA, J., BURCHELL, J., GENDLER, S., GILLET, C., and TAYLOR-PAPADIMITRIOU, J. (1989). A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal-antibody SM3 is selectively exposed in a range of primary carcinomas. Int. J. Cancer 43, 1072-1076.
16. GOEBEL, S.J., JOHNSON, G.P., PERKUS, M.E., DAVIS, S.W., WINSLOW, J.P., and PAOLETTI, E. (1990). The complete DNA sequence of vaccinia virus. Virology 179, 247-266.
17. GRANOWSKA, M., BIASSONI, L., CARROLL, M.J., HOWELL, R., MATHER, S.J., ELLISON, D., GRANOWSKI, A., and BRITTON, K.E. (1996). Breast-cancer TC-99 M SM3 radioimmunoscintigraphy. Acta Oncol. 35, 309-312.
18. GRIFFITH, T.S., WILEY, S.R., KUBIN, M.Z., SEDGER, L.M., MALISZEWSKI, C.R., and FANGER, N. (1999). Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J. Exp. Med. 189(8), 1343-1354.
19. GULLBERG, M., and COUTINHO, A. (1985). Activation of Lyt-2+ T cells by antibodies towards brain associated antigens. II. Antibody-dependent induction of "nonspecific" cell-mediated cytotoxicity. Eur. J. Immunol. 15, 971-976.
20. HERLYN, D.M., STEPLEWSKI, Z., HERLYN, M.F., and KOPROWSKI, H. (1980). Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res. 40, 717-721.
21. HERLYN, M., STEPLEWSKI, Z., HERLYN, D., and KOPROWSKI, H. (1979). Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 76, 1438-1442.
22. HOMBACH, A., KOCH, D., SIRCAR, R., HEUSER, C., DIEHL, V., KRUIS, W., POHL, C., and ABKEN, H. (1999). A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA. Gene Ther. 6, 300-304.
23. JAIN, R.K. (1989). Delivery of novel therapeutic agents in tumours: Physiological barriers and strategies. J. Natl. Cancer Inst. 81, 570-576.
24. KIENER, P.A., DAVIS, P.M., STARLING, G.C., MEHLIN, C., KLEBANOFF, S.J., LEDBETTER, J.A., and LILES, W.C. (1997). Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp. Med. 185(8), 1511-1516.
25. KIENY, M.P., LATHE, R., DRILLIEN, R., SPEHNER, D., SKORY, S., SCHMITT, D., WIKTOR, T., KOPROWSKI, H., and LECOCQ, J.P. (1984). Expression of the rabies virus glycoprotein from a recombinant vaccinia virus. Nature (London) 312, 163-166.
26. LEON, R.P., HEDLUND, T., MEECH, S.J., LI, S., SCHAACK, J., HUNGER, S.P., DUKE, R.C., and DEGREGORI, J. (1998). Adenoviral-mediated gene transfer in lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 95(22), 13159-13164.
27. LLOYD, K., BURCHELL, J., KUDRYASHOV, V., YIN, B.W.T., and TAYLOR-PAPADIMITRIOU, J. (1996). Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast eithelial cell lines and breast carcinoma cell lines-demonstration of simpler and fewer glycan chains in tumour cells. J. Biol. Chem. 271, 33325-33334.
28. MASUCCI, G., LINDELMALM, C., FRODIN, J.E., HAGSTROM, B., and MELLSTEDT, H. (1988). Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948). Hybridoma 7, 429-440.
29. OBERLING, F. (1997). Monocyte/macrophage as effector cells in cancer immunotherapy. Transfusion Sci. 182, 243-250.
30. OLD, L.J. (1996). Immunotherapy for cancer. Sci. Am. 275(3), 136-143.
31. PAUL, S., BIZOUARNE, N., PAUL, A., PRICE, M.R., HANSSON, G., KIENY, M.P., and ACRES, R.B. (1999). Lack of evidence for an immunosuppressive role for MUC1. Cancer Immunol. Immunother. 48, 22-28.
32. PAUL, S., BIZOUARNE, N., DOTT, K., RUET, L., DUFOUR, P., ACRES, R.B., and KIENY, M.P. (2000). Directed cellular cytotoxicity by infection of effector cells with a recombinant vaccinia virus encoding a tumour-specific monoclonal antibody. Cancer Gene Ther. 7, 615-623.
33. PELEGRIN, M., MARIN, M., NOEL, D., and PIECHACZYK, M. (1998). Genetically engineered antibodies in gene transfer and gene therapy. Hum. Gene Ther. 9, 2165-2175.
34. RAGNHAMMAR, P., MAGNUSSON, I., MASUCCI, G., and MELLSTEDT, H. (1993). The therapeutic use of the unconjugated monoclonal antibodies (Mab) 17-1A in combination with GM-CSF in the treatment of colorectal carcinoma (CRC). Med. Oncol. Tumour Pharmacother. 10, 61-70.
35. RIETHMULLER, G., SCHNEIDER-GADICKE, E., SCHLIMOK, G., SCHMIEGEL, W., RAAB, R., HOFFKEN, K., GRUBER, R., PICHLMAIER, H., HIRCHE, H., PICHLMAYR, R., BUGGISCH, P., WITTE, J., and the German Cancer Aid 17-1A Study Group. (1994). Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 343, 1177-1183.
36. ROSENBERG, S.A. (1992). Gene therapy for cancer. JAMA 268, 2416-2419.
37. SUBIZA, J.L., GIL, J., RODRIGUEZ, R., RUIZ DE MORALES, J.G., VINUELA, J.E., and DE LA CONCHA, E.G. (1992). Tumor cytostasis mediated by a monoclonal IgM antibody promoting adhesion between macrophages and tumor cells. Evidence for a lectin-like behavior. J. Immunol. 148, 2636-2642.
38. SUTTER, G., and MOSS, B. (1992). Nonreplicative vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. U.S.A. 89, 10847-10851.
39. TSARFATY, I., CHAITCHIK, S., HAREUVENI, M., HOREV, J., HIZI, A., WRESCHNER, D.H., and KEYDAR, I. (1989). H23 monoclonal antibody recognizes a breast tumor associated antigen: Clinical and molecular studies. In Breast Cancer Immunodiagnosis and Immunotherapy. R.L. Ceriani, ed. (Plenum Press, New York).
40. WANG, G., CHOPRA, R.K., ROYAL, R.E., YANG, J.C., ROSENBERG, S.A., and HWU, P. (1998). A T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-γ chain chimeric receptor gene recognizing a human ovarian cancer antigen. Nature Med. 2, 168-172.
41. WEIJTENS, M.E., WILLEMSEN, R.A., VALERIO, D., STAM, K., and BOLHUIS, R.L. (1996). Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity. J. Immunol. 157, 836-843.
42. 2+-dependent, Fas-and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage. J. Immunol. 159(1), 15-21.
43. YOSHIDA, R., YONEDA, Y., KURIYAMA, M., and KUBOTA, T. (1999). IFN-γ and cell-to-cell contact dependent cytotoxicity of allograft induced macrophages against syngeneic tumor cells and cell lines: An application of allografting to cancer treatment. J. Immunol. 163, 148-154.